Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Discovery

PUBLISHER: KBV Research | PRODUCT CODE: 1871326

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1871326

Global AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Regional Outlook and Forecast, 2025 - 2032

PUBLISHED:
PAGES: 600 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Multi User License)
USD 4320
PDF (Corporate User License)
USD 6048

Add to Cart

Description

Table of Contents

List of Tables

The Global AI In Drug Repurposing Market size is expected to reach $4.11 billion by 2032, rising at a market growth of 19.7% CAGR during the forecast period.

Key Highlights:

  • The North America market dominated Global AI In Drug Repurposing Market in 2024, accounting for a 42.30% revenue share in 2024.
  • The U.S. market is projected to maintain its leadership in North America, reaching a market size of USD 1.31 billion by 2032.
  • Among the Component, the Software & Platform segment dominated the global market, contributing a revenue share of 64.95% in 2024.
  • In terms of Technology, Machine Learning/Deep Learning segment are expected to lead the global market, with a projected revenue share of 40.63% by 2032.
  • The Pharmaceutical & BioTechnology Companies market emerged as the leading End Use in 2024, capturing a 58.41% revenue share, and is projected to retain its dominance during the forecast period.
  • The Oncology Market in Application is poised to grow at the market in 2032 with a market size of USD 1.28 billion and is projected to maintain its dominant position throughout the forecast period.

The pharmaceutical sector is experiencing a transformative shift as AI revolutionizes drug repurposing-identifying new therapeutic uses for existing compounds. Drug repurposing has developed into a systematic and data-driven approach powered by deep learning, graph-based models, and machine learning. By deploying vast biomedical datasets-including proteomics, clinical records, and genomics, AI now unveils complex drug-disease relationships that were not evident previously. This development has shifted AI-based repurposing from an experimental idea to a mainstream R&D strategy, supported by a strong partnership between technology providers and pharmaceutical companies. AI allows more efficient lifecycle management, enhanced targeting of unmet medical requirements, and faster drug discovery timelines.

The AI in Drug Repurposing market is anticipated to grow, driven by numerous trends. Repurposing is expanding into rescue programs and rare diseases for previously failed molecules, offering strategic as well as humanitarian advantages. Adaptive learning systems now allow continued model updates as new data emerges, improving long-term value and accuracy. Also, AI systems largely manage multimodal data and focus on explainability, providing mechanistic insights that clinical trust and build regulatory confidence. Market players deploy vertical partnerships, hybrid business models, and scalable AI platforms to support innovation. The market is witnessing intensive competition as the landscape is predicted to consolidate around a few integrated AI bio-ecosystems connected to pharma pipelines, with players emphasizing on rare conditions or specific therapeutic.

COVID 19 Impact Analysis

The COVID-19 pandemic sped up the use of AI in drug repurposing a lot, showing how important it is for pharmaceutical R&D. Organizations used AI to quickly screen existing compounds because they needed treatments right away. This cut the time it took to find new drugs from years to weeks. AI models were able to make better predictions because there was more data available on SARS-CoV-2. Preliminary success stories also made investors and the industry more confident. Public-private partnerships and collaborative data-sharing projects added to AI datasets, which led to new ideas for hybrid modeling approaches. As a result, AI repurposing went from being a test project to a key part of modern drug development, showing how it could change things even after the pandemic. Thus, the COVID-19 pandemic had a positive impact on the market.

Technology Outlook

Based on Technology, the market is segmented into Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), and Computer Vision. The natural language processing (NLP) segment witnessed 20% revenue share in the AI In drug repurposing market in 2024. Natural language processing plays a vital role in extracting insights from unstructured biomedical information such as research papers, patents, and clinical trial reports. NLP algorithms can scan millions of documents to identify potential drug-target or drug-disease connections by interpreting scientific language contextually.

End Use Outlook

Based on End Use, the market is segmented into Pharmaceutical & BioTechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, and Other End Use. The contract research organizations (CROs) segment recorded 20% revenue share in the AI In drug repurposing market in 2024. Contract research organizations are increasingly adopting AI-based platforms for drug repurposing to support pharmaceutical clients with data processing, clinical insights, and experimental validation. CROs use AI tools to design efficient trial protocols, identify drug candidates with repurposing potential, and model patient responses.

Regional Outlook

Region-wise, the AI In Drug Repurposing Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded 42% revenue share in the AI In Drug Repurposing Market in 2024. The AI in Drug Repurposing market is anticipated to grow at a significant rate in North America and Europe. This is due to large investment in pharma R&D, well-established ecosystem of AI startups collaborating CROs and big pharma, and extensive biomedical datasets (real-world evidence, EHRs, and genomics). Furthermore, the European market has strong translational research networks, well-established biotech and pharmaceutical clusters, and growing regulatory interest in AI-based tools, resulting in strong demand. Also, Europe focuses on data privacy deployments and regulatory alignment, which result in surging clinical validation of repurposing candidates.

In the Asia Pacific and LAMEA regions, the AI in Drug Repurposing market is expected to experience substantial expansion. This is driven by rapidly growing R&D spending in India, South Korea, and China, regional health/AI initiatives, rising biomedical data availability, and numerous partnerships between global pharma and regional AI providers. Moreover, the LAMEA region is also witnessing growth due to the rising clinical trial activity and increasing government digital health programs. The global collaborations and private investments target region-specific demands, particularly in nations with strong healthcare infrastructure.

List of Key Companies Profiled

  • Ginkgo Bioworks Holdings, Inc.
  • IBM Corporation
  • Atomwise, Inc.
  • Cyclica, Inc.
  • Genesis Healthcare Co.
  • Verge, Inc.
  • Novartis AG
  • Schrodinger, Inc
  • Recursion Pharmaceuticals, Inc.
  • The Cradle Company

Global AI In Drug Repurposing Market Report Segmentation

By Component

  • Software & Platform
  • Services

By Technology

  • Machine Learning/Deep Learning
  • Natural Language Processing (NLP)
  • Knowledge Graphs & Network-Based AI
  • Generative AI & Large Language Models (LLMs)
  • Computer Vision

By End Use

  • Pharmaceutical & BioTechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Other End Use

By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Rare & Orphan Diseases
  • Cardiology
  • Other Application

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Show more

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global AI In Drug Repurposing Market, by Component
    • 1.4.2 Global AI In Drug Repurposing Market, by Technology
    • 1.4.3 Global AI In Drug Repurposing Market, by End Use
    • 1.4.4 Global AI In Drug Repurposing Market, by Application
    • 1.4.5 Global AI In Drug Repurposing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Market Trends - AI In Drug Repurposing Market

Chapter 5. State of Competition - AI In Drug Repurposing Market

Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market

Chapter 7. Product Life Cycle - AI In Drug Repurposing Market

Chapter 8. Market Consolidation - AI In Drug Repurposing Market

Chapter 9. Key Customer Criteria - AI In Drug Repurposing Market

Chapter 10. Global AI In Drug Repurposing Market by Component

  • 10.1 Global Software & Platform Market by Region
  • 10.2 Global Services Market by Region

Chapter 11. Global AI In Drug Repurposing Market by Technology

  • 11.1 Global Machine Learning/Deep Learning Market by Region
  • 11.2 Global Natural Language Processing (NLP) Market by Region
  • 11.3 Global Knowledge Graphs & Network-Based AI Market by Region
  • 11.4 Global Generative AI & Large Language Models (LLMs) Market by Region
  • 11.5 Global Computer Vision Market by Region

Chapter 12. Global AI In Drug Repurposing Market by End Use

  • 12.1 Global Pharmaceutical & BioTechnology Companies Market by Region
  • 12.2 Global Contract Research Organizations (CROs) Market by Region
  • 12.3 Global Academic & Research Institutes Market by Region
  • 12.4 Global Other End Use Market by Region

Chapter 13. Global AI In Drug Repurposing Market by Application

  • 13.1 Global Oncology Market by Region
  • 13.2 Global Neurology Market by Region
  • 13.3 Global Infectious Diseases Market by Region
  • 13.4 Global Rare & Orphan Diseases Market by Region
  • 13.5 Global Cardiology Market by Region
  • 13.6 Global Other Application Market by Region

Chapter 14. Global AI In Drug Repurposing Market by Region

  • 14.1 North America AI In Drug Repurposing Market
  • 14.2 Key Factors Impacting the Market
    • 14.2.1 Market Drivers
    • 14.2.2 Market Restraints
    • 14.2.3 Market Opportunities
    • 14.2.4 Market Challenges
    • 14.2.5 Market Trends - North America AI In Drug Repurposing Market
    • 14.2.6 State of Competition - North American AI in Drug Repurposing Market
    • 14.2.7 North America AI In Drug Repurposing Market by Component
      • 14.2.7.1 North America Software & Platform Market by Country
      • 14.2.7.2 North America Services Market by Country
    • 14.2.8 North America AI In Drug Repurposing Market by Technology
      • 14.2.8.1 North America Machine Learning/Deep Learning Market by Region
      • 14.2.8.2 North America Natural Language Processing (NLP) Market by Region
      • 14.2.8.3 North America Knowledge Graphs & Network-Based AI Market by Region
      • 14.2.8.4 North America Generative AI & Large Language Models (LLMs) Market by Region
      • 14.2.8.5 North America Computer Vision Market by Region
    • 14.2.9 North America AI In Drug Repurposing Market by End Use
      • 14.2.9.1 North America Pharmaceutical & BioTechnology Companies Market by Country
      • 14.2.9.2 North America Contract Research Organizations (CROs) Market by Country
      • 14.2.9.3 North America Academic & Research Institutes Market by Country
      • 14.2.9.4 North America Other End Use Market by Country
    • 14.2.10 North America AI In Drug Repurposing Market by Application
      • 14.2.10.1 North America Oncology Market by Country
      • 14.2.10.2 North America Neurology Market by Country
      • 14.2.10.3 North America Infectious Diseases Market by Country
      • 14.2.10.4 North America Rare & Orphan Diseases Market by Country
      • 14.2.10.5 North America Cardiology Market by Country
      • 14.2.10.6 North America Other Application Market by Country
    • 14.2.11 North America AI In Drug Repurposing Market by Country
      • 14.2.11.1 US AI In Drug Repurposing Market
        • 14.2.11.1.1 US AI In Drug Repurposing Market by Component
        • 14.2.11.1.2 US AI In Drug Repurposing Market by Technology
        • 14.2.11.1.3 US AI In Drug Repurposing Market by End Use
        • 14.2.11.1.4 US AI In Drug Repurposing Market by Application
      • 14.2.11.2 Canada AI In Drug Repurposing Market
        • 14.2.11.2.1 Canada AI In Drug Repurposing Market by Component
        • 14.2.11.2.2 Canada AI In Drug Repurposing Market by Technology
        • 14.2.11.2.3 Canada AI In Drug Repurposing Market by End Use
        • 14.2.11.2.4 Canada AI In Drug Repurposing Market by Application
      • 14.2.11.3 Mexico AI In Drug Repurposing Market
        • 14.2.11.3.1 Mexico AI In Drug Repurposing Market by Component
        • 14.2.11.3.2 Mexico AI In Drug Repurposing Market by Technology
        • 14.2.11.3.3 Mexico AI In Drug Repurposing Market by End Use
        • 14.2.11.3.4 Mexico AI In Drug Repurposing Market by Application
      • 14.2.11.4 Rest of North America AI In Drug Repurposing Market
        • 14.2.11.4.1 Rest of North America AI In Drug Repurposing Market by Component
        • 14.2.11.4.2 Rest of North America AI In Drug Repurposing Market by Technology
        • 14.2.11.4.3 Rest of North America AI In Drug Repurposing Market by End Use
        • 14.2.11.4.4 Rest of North America AI In Drug Repurposing Market by Application
  • 14.3 Europe AI In Drug Repurposing Market
  • 14.4 Key Factors Impacting the Market
    • 14.4.1 Market Drivers
    • 14.4.2 Market Restraints
    • 14.4.3 Market Opportunities
    • 14.4.4 Market Challenges
    • 14.4.5 Market Trends - Europe AI In Drug Repurposing Market
    • 14.4.6 State of Competition - Europe AI in Drug Repurposing market
    • 14.4.7 Europe AI In Drug Repurposing Market by Component
      • 14.4.7.1 Europe Software & Platform Market by Country
      • 14.4.7.2 Europe Services Market by Country
    • 14.4.8 Europe AI In Drug Repurposing Market by Technology
      • 14.4.8.1 Europe Machine Learning/Deep Learning Market by Country
      • 14.4.8.2 Europe Natural Language Processing (NLP) Market by Country
      • 14.4.8.3 Europe Knowledge Graphs & Network-Based AI Market by Country
      • 14.4.8.4 Europe Generative AI & Large Language Models (LLMs) Market by Country
      • 14.4.8.5 Europe Computer Vision Market by Country
    • 14.4.9 Europe AI In Drug Repurposing Market by End Use
      • 14.4.9.1 Europe Pharmaceutical & BioTechnology Companies Market by Country
      • 14.4.9.2 Europe Contract Research Organizations (CROs) Market by Country
      • 14.4.9.3 Europe Academic & Research Institutes Market by Country
      • 14.4.9.4 Europe Other End Use Market by Country
    • 14.4.10 Europe AI In Drug Repurposing Market by Application
      • 14.4.10.1 Europe Oncology Market by Country
      • 14.4.10.2 Europe Neurology Market by Country
      • 14.4.10.3 Europe Infectious Diseases Market by Country
      • 14.4.10.4 Europe Rare & Orphan Diseases Market by Country
      • 14.4.10.5 Europe Cardiology Market by Country
      • 14.4.10.6 Europe Other Application Market by Country
    • 14.4.11 Europe AI In Drug Repurposing Market by Country
      • 14.4.11.1 Germany AI In Drug Repurposing Market
        • 14.4.11.1.1 Germany AI In Drug Repurposing Market by Component
        • 14.4.11.1.2 Germany AI In Drug Repurposing Market by Technology
        • 14.4.11.1.3 Germany AI In Drug Repurposing Market by End Use
        • 14.4.11.1.4 Germany AI In Drug Repurposing Market by Application
      • 14.4.11.2 UK AI In Drug Repurposing Market
        • 14.4.11.2.1 UK AI In Drug Repurposing Market by Component
        • 14.4.11.2.2 UK AI In Drug Repurposing Market by Technology
        • 14.4.11.2.3 UK AI In Drug Repurposing Market by End Use
        • 14.4.11.2.4 UK AI In Drug Repurposing Market by Application
      • 14.4.11.3 France AI In Drug Repurposing Market
        • 14.4.11.3.1 France AI In Drug Repurposing Market by Component
        • 14.4.11.3.2 France AI In Drug Repurposing Market by Technology
        • 14.4.11.3.3 France AI In Drug Repurposing Market by End Use
        • 14.4.11.3.4 France AI In Drug Repurposing Market by Application
      • 14.4.11.4 Russia AI In Drug Repurposing Market
        • 14.4.11.4.1 Russia AI In Drug Repurposing Market by Component
        • 14.4.11.4.2 Russia AI In Drug Repurposing Market by Technology
        • 14.4.11.4.3 Russia AI In Drug Repurposing Market by End Use
        • 14.4.11.4.4 Russia AI In Drug Repurposing Market by Application
      • 14.4.11.5 Spain AI In Drug Repurposing Market
        • 14.4.11.5.1 Spain AI In Drug Repurposing Market by Component
        • 14.4.11.5.2 Spain AI In Drug Repurposing Market by Technology
        • 14.4.11.5.3 Spain AI In Drug Repurposing Market by End Use
        • 14.4.11.5.4 Spain AI In Drug Repurposing Market by Application
      • 14.4.11.6 Italy AI In Drug Repurposing Market
        • 14.4.11.6.1 Italy AI In Drug Repurposing Market by Component
        • 14.4.11.6.2 Italy AI In Drug Repurposing Market by Technology
        • 14.4.11.6.3 Italy AI In Drug Repurposing Market by End Use
        • 14.4.11.6.4 Italy AI In Drug Repurposing Market by Application
      • 14.4.11.7 Rest of Europe AI In Drug Repurposing Market
        • 14.4.11.7.1 Rest of Europe AI In Drug Repurposing Market by Component
        • 14.4.11.7.2 Rest of Europe AI In Drug Repurposing Market by Technology
        • 14.4.11.7.3 Rest of Europe AI In Drug Repurposing Market by End Use
        • 14.4.11.7.4 Rest of Europe AI In Drug Repurposing Market by Application
  • 14.5 Asia Pacific AI In Drug Repurposing Market
  • 14.6 Key Factors Impacting the Market
    • 14.6.1 Market Drivers
    • 14.6.2 Market Restraints
    • 14.6.3 Market Opportunities
    • 14.6.4 Market Challenges
    • 14.6.5 Market Trends - Asia Pacific AI In Drug Repurposing Market
    • 14.6.6 State of Competition - Asia Pacific AI In Drug Repurposing Market
    • 14.6.7 Asia Pacific AI In Drug Repurposing Market by Component
      • 14.6.7.1 Asia Pacific Software & Platform Market by Country
      • 14.6.7.2 Asia Pacific Services Market by Country
    • 14.6.8 Asia Pacific AI In Drug Repurposing Market by Technology
      • 14.6.8.1 Asia Pacific Machine Learning/Deep Learning Market by Country
      • 14.6.8.2 Asia Pacific Natural Language Processing (NLP) Market by Country
      • 14.6.8.3 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country
      • 14.6.8.4 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country
      • 14.6.8.5 Asia Pacific Computer Vision Market by Country
    • 14.6.9 Asia Pacific AI In Drug Repurposing Market by End Use
      • 14.6.9.1 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country
      • 14.6.9.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
      • 14.6.9.3 Asia Pacific Academic & Research Institutes Market by Country
      • 14.6.9.4 Asia Pacific Other End Use Market by Country
    • 14.6.10 Asia Pacific AI In Drug Repurposing Market by Application
      • 14.6.10.1 Asia Pacific Oncology Market by Country
      • 14.6.10.2 Asia Pacific Neurology Market by Country
      • 14.6.10.3 Asia Pacific Infectious Diseases Market by Country
      • 14.6.10.4 Asia Pacific Rare & Orphan Diseases Market by Country
      • 14.6.10.5 Asia Pacific Cardiology Market by Country
      • 14.6.10.6 Asia Pacific Other Application Market by Country
    • 14.6.11 Asia Pacific AI In Drug Repurposing Market by Country
      • 14.6.11.1 China AI In Drug Repurposing Market
        • 14.6.11.1.1 China AI In Drug Repurposing Market by Component
        • 14.6.11.1.2 China AI In Drug Repurposing Market by Technology
        • 14.6.11.1.3 China AI In Drug Repurposing Market by End Use
        • 14.6.11.1.4 China AI In Drug Repurposing Market by Application
      • 14.6.11.2 Japan AI In Drug Repurposing Market
        • 14.6.11.2.1 Japan AI In Drug Repurposing Market by Component
        • 14.6.11.2.2 Japan AI In Drug Repurposing Market by Technology
        • 14.6.11.2.3 Japan AI In Drug Repurposing Market by End Use
        • 14.6.11.2.4 Japan AI In Drug Repurposing Market by Application
      • 14.6.11.3 India AI In Drug Repurposing Market
        • 14.6.11.3.1 India AI In Drug Repurposing Market by Component
        • 14.6.11.3.2 India AI In Drug Repurposing Market by Technology
        • 14.6.11.3.3 India AI In Drug Repurposing Market by End Use
        • 14.6.11.3.4 India AI In Drug Repurposing Market by Application
      • 14.6.11.4 South Korea AI In Drug Repurposing Market
        • 14.6.11.4.1 South Korea AI In Drug Repurposing Market by Component
        • 14.6.11.4.2 South Korea AI In Drug Repurposing Market by Technology
        • 14.6.11.4.3 South Korea AI In Drug Repurposing Market by End Use
        • 14.6.11.4.4 South Korea AI In Drug Repurposing Market by Application
      • 14.6.11.5 Singapore AI In Drug Repurposing Market
        • 14.6.11.5.1 Singapore AI In Drug Repurposing Market by Component
        • 14.6.11.5.2 Singapore AI In Drug Repurposing Market by Technology
        • 14.6.11.5.3 Singapore AI In Drug Repurposing Market by End Use
        • 14.6.11.5.4 Singapore AI In Drug Repurposing Market by Application
      • 14.6.11.6 Malaysia AI In Drug Repurposing Market
        • 14.6.11.6.1 Malaysia AI In Drug Repurposing Market by Component
        • 14.6.11.6.2 Malaysia AI In Drug Repurposing Market by Technology
        • 14.6.11.6.3 Malaysia AI In Drug Repurposing Market by End Use
        • 14.6.11.6.4 Malaysia AI In Drug Repurposing Market by Application
      • 14.6.11.7 Rest of Asia Pacific AI In Drug Repurposing Market
        • 14.6.11.7.1 Rest of Asia Pacific AI In Drug Repurposing Market by Component
        • 14.6.11.7.2 Rest of Asia Pacific AI In Drug Repurposing Market by Technology
        • 14.6.11.7.3 Rest of Asia Pacific AI In Drug Repurposing Market by End Use
        • 14.6.11.7.4 Rest of Asia Pacific AI In Drug Repurposing Market by Application
  • 14.7 LAMEA AI In Drug Repurposing Market
  • 14.8 Key Factors Impacting the Market
    • 14.8.1 Market Drivers
    • 14.8.2 Market Restraints
    • 14.8.3 Market Opportunities
    • 14.8.4 Market Challenges
    • 14.8.5 Market Trends - LAMEA AI In Drug Repurposing Market
    • 14.8.6 State of Competition - LAMEA AI in Drug Repurposing market
    • 14.8.7 LAMEA AI In Drug Repurposing Market by Component
      • 14.8.7.1 LAMEA Software & Platform Market by Country
      • 14.8.7.2 LAMEA Services Market by Country
    • 14.8.8 LAMEA AI In Drug Repurposing Market by Technology
      • 14.8.8.1 LAMEA Machine Learning/Deep Learning Market by Country
      • 14.8.8.2 LAMEA Natural Language Processing (NLP) Market by Country
      • 14.8.8.3 LAMEA Knowledge Graphs & Network-Based AI Market by Country
      • 14.8.8.4 LAMEA Generative AI & Large Language Models (LLMs) Market by Country
      • 14.8.8.5 LAMEA Computer Vision Market by Country
    • 14.8.9 LAMEA AI In Drug Repurposing Market by End Use
      • 14.8.9.1 LAMEA Pharmaceutical & BioTechnology Companies Market by Country
      • 14.8.9.2 LAMEA Contract Research Organizations (CROs) Market by Country
      • 14.8.9.3 LAMEA Academic & Research Institutes Market by Country
      • 14.8.9.4 LAMEA Other End Use Market by Country
    • 14.8.10 LAMEA AI In Drug Repurposing Market by Application
      • 14.8.10.1 LAMEA Oncology Market by Country
      • 14.8.10.2 LAMEA Neurology Market by Country
      • 14.8.10.3 LAMEA Infectious Diseases Market by Country
      • 14.8.10.4 LAMEA Rare & Orphan Diseases Market by Country
      • 14.8.10.5 LAMEA Cardiology Market by Country
      • 14.8.10.6 LAMEA Other Application Market by Country
    • 14.8.11 LAMEA AI In Drug Repurposing Market by Country
      • 14.8.11.1 Brazil AI In Drug Repurposing Market
        • 14.8.11.1.1 Brazil AI In Drug Repurposing Market by Component
        • 14.8.11.1.2 Brazil AI In Drug Repurposing Market by Technology
        • 14.8.11.1.3 Brazil AI In Drug Repurposing Market by End Use
        • 14.8.11.1.4 Brazil AI In Drug Repurposing Market by Application
      • 14.8.11.2 Argentina AI In Drug Repurposing Market
        • 14.8.11.2.1 Argentina AI In Drug Repurposing Market by Component
        • 14.8.11.2.2 Argentina AI In Drug Repurposing Market by Technology
        • 14.8.11.2.3 Argentina AI In Drug Repurposing Market by End Use
        • 14.8.11.2.4 Argentina AI In Drug Repurposing Market by Application
      • 14.8.11.3 UAE AI In Drug Repurposing Market
        • 14.8.11.3.1 UAE AI In Drug Repurposing Market by Component
        • 14.8.11.3.2 UAE AI In Drug Repurposing Market by Technology
        • 14.8.11.3.3 UAE AI In Drug Repurposing Market by End Use
        • 14.8.11.3.4 UAE AI In Drug Repurposing Market by Application
      • 14.8.11.4 Saudi Arabia AI In Drug Repurposing Market
        • 14.8.11.4.1 Saudi Arabia AI In Drug Repurposing Market by Component
        • 14.8.11.4.2 Saudi Arabia AI In Drug Repurposing Market by Technology
        • 14.8.11.4.3 Saudi Arabia AI In Drug Repurposing Market by End Use
        • 14.8.11.4.4 Saudi Arabia AI In Drug Repurposing Market by Application
      • 14.8.11.5 South Africa AI In Drug Repurposing Market
        • 14.8.11.5.1 South Africa AI In Drug Repurposing Market by Component
        • 14.8.11.5.2 South Africa AI In Drug Repurposing Market by Technology
        • 14.8.11.5.3 South Africa AI In Drug Repurposing Market by End Use
        • 14.8.11.5.4 South Africa AI In Drug Repurposing Market by Application
      • 14.8.11.6 Nigeria AI In Drug Repurposing Market
        • 14.8.11.6.1 Nigeria AI In Drug Repurposing Market by Component
        • 14.8.11.6.2 Nigeria AI In Drug Repurposing Market by Technology
        • 14.8.11.6.3 Nigeria AI In Drug Repurposing Market by End Use
        • 14.8.11.6.4 Nigeria AI In Drug Repurposing Market by Application
      • 14.8.11.7 Rest of LAMEA AI In Drug Repurposing Market
        • 14.8.11.7.1 Rest of LAMEA AI In Drug Repurposing Market by Component
        • 14.8.11.7.2 Rest of LAMEA AI In Drug Repurposing Market by Technology
        • 14.8.11.7.3 Rest of LAMEA AI In Drug Repurposing Market by End Use
        • 14.8.11.7.4 Rest of LAMEA AI In Drug Repurposing Market by Application

Chapter 15. Company Profiles

  • 15.1 Ginkgo Bioworks Holdings, Inc.
    • 15.1.1 Company Overview
    • 15.1.2 Financial Analysis
    • 15.1.3 Segmental and Regional Analysis
    • 15.1.4 Research & Development Expenses
    • 15.1.5 Recent strategies and developments:
      • 15.1.5.1 Partnerships, Collaborations, and Agreements:
    • 15.1.6 SWOT Analysis
  • 15.2 IBM Corporation
    • 15.2.1 Company Overview
    • 15.2.2 Financial Analysis
    • 15.2.3 Regional & Segmental Analysis
    • 15.2.4 Research & Development Expenses
    • 15.2.5 Recent strategies and developments:
      • 15.2.5.1 Partnerships, Collaborations, and Agreements:
    • 15.2.6 SWOT Analysis
  • 15.3 Atomwise, Inc.
    • 15.3.1 Company Overview
  • 15.4 Cyclica, Inc.
    • 15.4.1 Company Overview
  • 15.5 Genesis Healthcare Co.
    • 15.5.1 Company Overview
  • 15.6 Verge, Inc.
    • 15.6.1 Company Overview
  • 15.7 Novartis AG
    • 15.7.1 Company Overview
    • 15.7.2 Financial Analysis
    • 15.7.3 Segmental and Regional Analysis
    • 15.7.4 Research & Development Expenses
    • 15.7.5 SWOT Analysis
  • 15.8 Schrodinger, Inc
    • 15.8.1 Company Overview
    • 15.8.2 Financial Analysis
    • 15.8.3 Segmental and Regional Analysis
    • 15.8.4 Research & Development Expenses
  • 15.9 Recursion Pharmaceuticals, Inc.
    • 15.9.1 Company Overview
    • 15.9.2 Financial Analysis
    • 15.9.3 Research & Development Expenses
  • 15.10. The Cradle Company
    • 15.10.1 Company Overview

Chapter 16. Winning Imperatives of AI In Drug Repurposing Market

Show more

LIST OF TABLES

  • TABLE 1 Global AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 2 Global AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
  • TABLE 4 Global AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 5 Global AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 6 Global Software & Platform Market by Region, 2021 - 2024, USD Million
  • TABLE 7 Global Software & Platform Market by Region, 2025 - 2032, USD Million
  • TABLE 8 Global Services Market by Region, 2021 - 2024, USD Million
  • TABLE 9 Global Services Market by Region, 2025 - 2032, USD Million
  • TABLE 10 Global AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 11 Global AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 12 Global Machine Learning/Deep Learning Market by Region, 2021 - 2024, USD Million
  • TABLE 13 Global Machine Learning/Deep Learning Market by Region, 2025 - 2032, USD Million
  • TABLE 14 Global Natural Language Processing (NLP) Market by Region, 2021 - 2024, USD Million
  • TABLE 15 Global Natural Language Processing (NLP) Market by Region, 2025 - 2032, USD Million
  • TABLE 16 Global Knowledge Graphs & Network-Based AI Market by Region, 2021 - 2024, USD Million
  • TABLE 17 Global Knowledge Graphs & Network-Based AI Market by Region, 2025 - 2032, USD Million
  • TABLE 18 Global Generative AI & Large Language Models (LLMs) Market by Region, 2021 - 2024, USD Million
  • TABLE 19 Global Generative AI & Large Language Models (LLMs) Market by Region, 2025 - 2032, USD Million
  • TABLE 20 Global Computer Vision Market by Region, 2021 - 2024, USD Million
  • TABLE 21 Global Computer Vision Market by Region, 2025 - 2032, USD Million
  • TABLE 22 Global AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 23 Global AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 24 Global Pharmaceutical & BioTechnology Companies Market by Region, 2021 - 2024, USD Million
  • TABLE 25 Global Pharmaceutical & BioTechnology Companies Market by Region, 2025 - 2032, USD Million
  • TABLE 26 Global Contract Research Organizations (CROs) Market by Region, 2021 - 2024, USD Million
  • TABLE 27 Global Contract Research Organizations (CROs) Market by Region, 2025 - 2032, USD Million
  • TABLE 28 Global Academic & Research Institutes Market by Region, 2021 - 2024, USD Million
  • TABLE 29 Global Academic & Research Institutes Market by Region, 2025 - 2032, USD Million
  • TABLE 30 Global Other End Use Market by Region, 2021 - 2024, USD Million
  • TABLE 31 Global Other End Use Market by Region, 2025 - 2032, USD Million
  • TABLE 32 Global AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 33 Global AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 34 Global Oncology Market by Region, 2021 - 2024, USD Million
  • TABLE 35 Global Oncology Market by Region, 2025 - 2032, USD Million
  • TABLE 36 Global Neurology Market by Region, 2021 - 2024, USD Million
  • TABLE 37 Global Neurology Market by Region, 2025 - 2032, USD Million
  • TABLE 38 Global Infectious Diseases Market by Region, 2021 - 2024, USD Million
  • TABLE 39 Global Infectious Diseases Market by Region, 2025 - 2032, USD Million
  • TABLE 40 Global Rare & Orphan Diseases Market by Region, 2021 - 2024, USD Million
  • TABLE 41 Global Rare & Orphan Diseases Market by Region, 2025 - 2032, USD Million
  • TABLE 42 Global Cardiology Market by Region, 2021 - 2024, USD Million
  • TABLE 43 Global Cardiology Market by Region, 2025 - 2032, USD Million
  • TABLE 44 Global Other Application Market by Region, 2021 - 2024, USD Million
  • TABLE 45 Global Other Application Market by Region, 2025 - 2032, USD Million
  • TABLE 46 Global AI In Drug Repurposing Market by Region, 2021 - 2024, USD Million
  • TABLE 47 Global AI In Drug Repurposing Market by Region, 2025 - 2032, USD Million
  • TABLE 48 North America AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 49 North America AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 50 North America AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 51 North America AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 52 North America Software & Platform Market by Country, 2021 - 2024, USD Million
  • TABLE 53 North America Software & Platform Market by Country, 2025 - 2032, USD Million
  • TABLE 54 North America Services Market by Country, 2021 - 2024, USD Million
  • TABLE 55 North America Services Market by Country, 2025 - 2032, USD Million
  • TABLE 56 North America AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 57 North America AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 58 North America Machine Learning/Deep Learning Market by Region, 2021 - 2024, USD Million
  • TABLE 59 North America Machine Learning/Deep Learning Market by Region, 2025 - 2032, USD Million
  • TABLE 60 North America Natural Language Processing (NLP) Market by Region, 2021 - 2024, USD Million
  • TABLE 61 North America Natural Language Processing (NLP) Market by Region, 2025 - 2032, USD Million
  • TABLE 62 North America Knowledge Graphs & Network-Based AI Market by Region, 2021 - 2024, USD Million
  • TABLE 63 North America Knowledge Graphs & Network-Based AI Market by Region, 2025 - 2032, USD Million
  • TABLE 64 North America Generative AI & Large Language Models (LLMs) Market by Region, 2021 - 2024, USD Million
  • TABLE 65 North America Generative AI & Large Language Models (LLMs) Market by Region, 2025 - 2032, USD Million
  • TABLE 66 North America Computer Vision Market by Region, 2021 - 2024, USD Million
  • TABLE 67 North America Computer Vision Market by Region, 2025 - 2032, USD Million
  • TABLE 68 North America AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 69 North America AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 70 North America Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
  • TABLE 71 North America Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
  • TABLE 72 North America Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
  • TABLE 73 North America Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
  • TABLE 74 North America Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
  • TABLE 75 North America Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
  • TABLE 76 North America Other End Use Market by Country, 2021 - 2024, USD Million
  • TABLE 77 North America Other End Use Market by Country, 2025 - 2032, USD Million
  • TABLE 78 North America AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 79 North America AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 80 North America Oncology Market by Country, 2021 - 2024, USD Million
  • TABLE 81 North America Oncology Market by Country, 2025 - 2032, USD Million
  • TABLE 82 North America Neurology Market by Country, 2021 - 2024, USD Million
  • TABLE 83 North America Neurology Market by Country, 2025 - 2032, USD Million
  • TABLE 84 North America Infectious Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 85 North America Infectious Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 86 North America Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 87 North America Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 88 North America Cardiology Market by Country, 2021 - 2024, USD Million
  • TABLE 89 North America Cardiology Market by Country, 2025 - 2032, USD Million
  • TABLE 90 North America Other Application Market by Country, 2021 - 2024, USD Million
  • TABLE 91 North America Other Application Market by Country, 2025 - 2032, USD Million
  • TABLE 92 North America AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
  • TABLE 93 North America AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
  • TABLE 94 US AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 95 US AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 96 US AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 97 US AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 98 US AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 99 US AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 100 US AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 101 US AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 102 US AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 103 US AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 104 Canada AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 105 Canada AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 106 Canada AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 107 Canada AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 108 Canada AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 109 Canada AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 110 Canada AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 111 Canada AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 112 Canada AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 113 Canada AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 114 Mexico AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 115 Mexico AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 116 Mexico AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 117 Mexico AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 118 Mexico AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 119 Mexico AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 120 Mexico AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 121 Mexico AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 122 Mexico AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 123 Mexico AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 124 Rest of North America AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 125 Rest of North America AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 126 Rest of North America AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 127 Rest of North America AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 128 Rest of North America AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 129 Rest of North America AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 130 Rest of North America AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 131 Rest of North America AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 132 Rest of North America AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 133 Rest of North America AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 134 Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 135 Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 136 Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 137 Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 138 Europe Software & Platform Market by Country, 2021 - 2024, USD Million
  • TABLE 139 Europe Software & Platform Market by Country, 2025 - 2032, USD Million
  • TABLE 140 Europe Services Market by Country, 2021 - 2024, USD Million
  • TABLE 141 Europe Services Market by Country, 2025 - 2032, USD Million
  • TABLE 142 Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 143 Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 144 Europe Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
  • TABLE 145 Europe Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
  • TABLE 146 Europe Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
  • TABLE 147 Europe Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
  • TABLE 148 Europe Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
  • TABLE 149 Europe Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
  • TABLE 150 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
  • TABLE 151 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
  • TABLE 152 Europe Computer Vision Market by Country, 2021 - 2024, USD Million
  • TABLE 153 Europe Computer Vision Market by Country, 2025 - 2032, USD Million
  • TABLE 154 Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 155 Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 156 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
  • TABLE 157 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
  • TABLE 158 Europe Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
  • TABLE 159 Europe Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
  • TABLE 160 Europe Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
  • TABLE 161 Europe Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
  • TABLE 162 Europe Other End Use Market by Country, 2021 - 2024, USD Million
  • TABLE 163 Europe Other End Use Market by Country, 2025 - 2032, USD Million
  • TABLE 164 Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 165 Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 166 Europe Oncology Market by Country, 2021 - 2024, USD Million
  • TABLE 167 Europe Oncology Market by Country, 2025 - 2032, USD Million
  • TABLE 168 Europe Neurology Market by Country, 2021 - 2024, USD Million
  • TABLE 169 Europe Neurology Market by Country, 2025 - 2032, USD Million
  • TABLE 170 Europe Infectious Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 171 Europe Infectious Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 172 Europe Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 173 Europe Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 174 Europe Cardiology Market by Country, 2021 - 2024, USD Million
  • TABLE 175 Europe Cardiology Market by Country, 2025 - 2032, USD Million
  • TABLE 176 Europe Other End Use Market by Country, 2021 - 2024, USD Million
  • TABLE 177 Europe Other End Use Market by Country, 2025 - 2032, USD Million
  • TABLE 178 Europe AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
  • TABLE 179 Europe AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
  • TABLE 180 Germany AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 181 Germany AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 182 Germany AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 183 Germany AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 184 Germany AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 185 Germany AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 186 Germany AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 187 Germany AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 188 Germany AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 189 Germany AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 190 UK AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 191 UK AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 192 UK AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 193 UK AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 194 UK AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 195 UK AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 196 UK AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 197 UK AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 198 UK AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 199 UK AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 200 France AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 201 France AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 202 France AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 203 France AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 204 France AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 205 France AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 206 France AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 207 France AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 208 France AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 209 France AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 210 Russia AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 211 Russia AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 212 Russia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 213 Russia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 214 Russia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 215 Russia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 216 Russia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 217 Russia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 218 Russia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 219 Russia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 220 Spain AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 221 Spain AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 222 Spain AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 223 Spain AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 224 Spain AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 225 Spain AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 226 Spain AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 227 Spain AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 228 Spain AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 229 Spain AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 230 Italy AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 231 Italy AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 232 Italy AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 233 Italy AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 234 Italy AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 235 Italy AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 236 Italy AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 237 Italy AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 238 Italy AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 239 Italy AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 240 Rest of Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 241 Rest of Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 242 Rest of Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 243 Rest of Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 244 Rest of Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 245 Rest of Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 246 Rest of Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 247 Rest of Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 248 Rest of Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 249 Rest of Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 250 Asia Pacific AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 251 Asia Pacific AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 252 Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 253 Asia Pacific AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 254 Asia Pacific Software & Platform Market by Country, 2021 - 2024, USD Million
  • TABLE 255 Asia Pacific Software & Platform Market by Country, 2025 - 2032, USD Million
  • TABLE 256 Asia Pacific Services Market by Country, 2021 - 2024, USD Million
  • TABLE 257 Asia Pacific Services Market by Country, 2025 - 2032, USD Million
  • TABLE 258 Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 259 Asia Pacific AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 260 Asia Pacific Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
  • TABLE 261 Asia Pacific Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
  • TABLE 262 Asia Pacific Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
  • TABLE 263 Asia Pacific Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
  • TABLE 264 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
  • TABLE 265 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
  • TABLE 266 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
  • TABLE 267 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
  • TABLE 268 Asia Pacific Computer Vision Market by Country, 2021 - 2024, USD Million
  • TABLE 269 Asia Pacific Computer Vision Market by Country, 2025 - 2032, USD Million
  • TABLE 270 Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 271 Asia Pacific AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 272 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
  • TABLE 273 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
  • TABLE 274 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
  • TABLE 275 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
  • TABLE 276 Asia Pacific Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
  • TABLE 277 Asia Pacific Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
  • TABLE 278 Asia Pacific Other End Use Market by Country, 2021 - 2024, USD Million
  • TABLE 279 Asia Pacific Other End Use Market by Country, 2025 - 2032, USD Million
  • TABLE 280 Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 281 Asia Pacific AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 282 Asia Pacific Oncology Market by Country, 2021 - 2024, USD Million
  • TABLE 283 Asia Pacific Oncology Market by Country, 2025 - 2032, USD Million
  • TABLE 284 Asia Pacific Neurology Market by Country, 2021 - 2024, USD Million
  • TABLE 285 Asia Pacific Neurology Market by Country, 2025 - 2032, USD Million
  • TABLE 286 Asia Pacific Infectious Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 287 Asia Pacific Infectious Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 288 Asia Pacific Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 289 Asia Pacific Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 290 Asia Pacific Cardiology Market by Country, 2021 - 2024, USD Million
  • TABLE 291 Asia Pacific Cardiology Market by Country, 2025 - 2032, USD Million
  • TABLE 292 Asia Pacific Other Application Market by Country, 2021 - 2024, USD Million
  • TABLE 293 Asia Pacific Other Application Market by Country, 2025 - 2032, USD Million
  • TABLE 294 Asia Pacific AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
  • TABLE 295 Asia Pacific AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
  • TABLE 296 China AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 297 China AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 298 China AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 299 China AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 300 China AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 301 China AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 302 China AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 303 China AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 304 China AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 305 China AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 306 Japan AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 307 Japan AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 308 Japan AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 309 Japan AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 310 Japan AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 311 Japan AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 312 Japan AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 313 Japan AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 314 Japan AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 315 Japan AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 316 India AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 317 India AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 318 India AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 319 India AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 320 India AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 321 India AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 322 India AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 323 India AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 324 India AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 325 India AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 326 South Korea AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 327 South Korea AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 328 South Korea AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 329 South Korea AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 330 South Korea AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 331 South Korea AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 332 South Korea AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 333 South Korea AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 334 South Korea AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 335 South Korea AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 336 Singapore AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 337 Singapore AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 338 Singapore AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 339 Singapore AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 340 Singapore AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 341 Singapore AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 342 Singapore AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 343 Singapore AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 344 Singapore AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 345 Singapore AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 346 Malaysia AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 347 Malaysia AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 348 Malaysia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 349 Malaysia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 350 Malaysia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 351 Malaysia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 352 Malaysia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 353 Malaysia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 354 Malaysia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 355 Malaysia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 356 Rest of Asia Pacific AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 357 Rest of Asia Pacific AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 358 Rest of Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 359 Rest of Asia Pacific AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 360 Rest of Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 361 Rest of Asia Pacific AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 362 Rest of Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 363 Rest of Asia Pacific AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 364 Rest of Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 365 Rest of Asia Pacific AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 366 LAMEA AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 367 LAMEA AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 368 LAMEA AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 369 LAMEA AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 370 LAMEA Software & Platform Market by Country, 2021 - 2024, USD Million
  • TABLE 371 LAMEA Software & Platform Market by Country, 2025 - 2032, USD Million
  • TABLE 372 LAMEA Services Market by Country, 2021 - 2024, USD Million
  • TABLE 373 LAMEA Services Market by Country, 2025 - 2032, USD Million
  • TABLE 374 LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 375 LAMEA AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 376 LAMEA Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
  • TABLE 377 LAMEA Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
  • TABLE 378 LAMEA Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
  • TABLE 379 LAMEA Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
  • TABLE 380 LAMEA Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
  • TABLE 381 LAMEA Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
  • TABLE 382 LAMEA Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
  • TABLE 383 LAMEA Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
  • TABLE 384 LAMEA Computer Vision Market by Country, 2021 - 2024, USD Million
  • TABLE 385 LAMEA Computer Vision Market by Country, 2025 - 2032, USD Million
  • TABLE 386 LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 387 LAMEA AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 388 LAMEA Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
  • TABLE 389 LAMEA Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
  • TABLE 390 LAMEA Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
  • TABLE 391 LAMEA Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
  • TABLE 392 LAMEA Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
  • TABLE 393 LAMEA Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
  • TABLE 394 LAMEA Other End Use Market by Country, 2021 - 2024, USD Million
  • TABLE 395 LAMEA Other End Use Market by Country, 2025 - 2032, USD Million
  • TABLE 396 LAMEA AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 397 LAMEA AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 398 LAMEA Oncology Market by Country, 2021 - 2024, USD Million
  • TABLE 399 LAMEA Oncology Market by Country, 2025 - 2032, USD Million
  • TABLE 400 LAMEA Neurology Market by Country, 2021 - 2024, USD Million
  • TABLE 401 LAMEA Neurology Market by Country, 2025 - 2032, USD Million
  • TABLE 402 LAMEA Infectious Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 403 LAMEA Infectious Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 404 LAMEA Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
  • TABLE 405 LAMEA Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
  • TABLE 406 LAMEA Cardiology Market by Country, 2021 - 2024, USD Million
  • TABLE 407 LAMEA Cardiology Market by Country, 2025 - 2032, USD Million
  • TABLE 408 LAMEA Other Application Market by Country, 2021 - 2024, USD Million
  • TABLE 409 LAMEA Other Application Market by Country, 2025 - 2032, USD Million
  • TABLE 410 LAMEA AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
  • TABLE 411 LAMEA AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
  • TABLE 412 Brazil AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 413 Brazil AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 414 Brazil AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 415 Brazil AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 416 Brazil AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 417 Brazil AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 418 Brazil AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 419 Brazil AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 420 Brazil AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 421 Brazil AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 422 Argentina AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 423 Argentina AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 424 Argentina AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 425 Argentina AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 426 Argentina AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 427 Argentina AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 428 Argentina AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 429 Argentina AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 430 Argentina AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 431 Argentina AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 432 UAE AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 433 UAE AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 434 UAE AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 435 UAE AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 436 UAE AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 437 UAE AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 438 UAE AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 439 UAE AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 440 UAE AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 441 UAE AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 442 Saudi Arabia AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 443 Saudi Arabia AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 444 Saudi Arabia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 445 Saudi Arabia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 446 Saudi Arabia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 447 Saudi Arabia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 448 Saudi Arabia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 449 Saudi Arabia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 450 Saudi Arabia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 451 Saudi Arabia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 452 South Africa AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 453 South Africa AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 454 South Africa AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 455 South Africa AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 456 South Africa AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 457 South Africa AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 458 South Africa AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 459 South Africa AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 460 South Africa AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 461 South Africa AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 462 Nigeria AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 463 Nigeria AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 464 Nigeria AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 465 Nigeria AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 466 Nigeria AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 467 Nigeria AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 468 Nigeria AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 469 Nigeria AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 470 Nigeria AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 471 Nigeria AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 472 Rest of LAMEA AI In Drug Repurposing Market, 2021 - 2024, USD Million
  • TABLE 473 Rest of LAMEA AI In Drug Repurposing Market, 2025 - 2032, USD Million
  • TABLE 474 Rest of LAMEA AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
  • TABLE 475 Rest of LAMEA AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
  • TABLE 476 Rest of LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
  • TABLE 477 Rest of LAMEA AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
  • TABLE 478 Rest of LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
  • TABLE 479 Rest of LAMEA AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
  • TABLE 480 Rest of LAMEA AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
  • TABLE 481 Rest of LAMEA AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
  • TABLE 482 Key Information - GINKGO BIOWORKS HOLDINGS, INC.
  • TABLE 483 Key Information - IBM Corporation
  • TABLE 484 Key Information - Atomwise, Inc.
  • TABLE 485 Key Information - Cyclica, Inc.
  • TABLE 486 Key Information - Genesis Healthcare Co.
  • TABLE 487 Key Information - Verge, Inc.
  • TABLE 488 Key Information - Novartis AG
  • TABLE 489 Key Information - Schrodinger, Inc
  • TABLE 490 Key Information - Recursion Pharmaceuticals, Inc.
  • TABLE 491 Key Information - The Cradle Company

LIST OF FIGURES

  • FIG 1 Methodology for the research
  • FIG 2 Global AI In Drug Repurposing Market, 2021 - 2032, USD Million
  • FIG 3 Key Factors Impacting AI In Drug Repurposing Market
  • FIG 4 Porter's Five Forces Analysis - AI In Drug Repurposing Market
  • FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
  • FIG 6 Product Life Cycle - AI In Drug Repurposing Market
  • FIG 7 Market Consolidation - AI In Drug Repurposing Market
  • FIG 8 Key Customer Criteria - AI In Drug Repurposing Market
  • FIG 9 Global AI In Drug Repurposing Market share by Component, 2024
  • FIG 10 Global AI In Drug Repurposing Market share by Component, 2032
  • FIG 11 Global AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
  • FIG 12 Global AI In Drug Repurposing Market share by Technology, 2024
  • FIG 13 Global AI In Drug Repurposing Market share by Technology, 2032
  • FIG 14 Global AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
  • FIG 15 Global AI In Drug Repurposing Market share by End Use, 2024
  • FIG 16 Global AI In Drug Repurposing Market share by End Use, 2032
  • FIG 17 Global AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
  • FIG 18 Global AI In Drug Repurposing Market share by Application, 2024
  • FIG 19 Global AI In Drug Repurposing Market share by Application, 2032
  • FIG 20 Global AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
  • FIG 21 Global AI In Drug Repurposing Market share by Region, 2024
  • FIG 22 Global AI In Drug Repurposing Market share by Region, 2032
  • FIG 23 Global AI In Drug Repurposing Market by Region, 2021 - 2032, USD Million
  • FIG 24 Key Factors Impacting north America AI In Drug Repurposing Market
  • FIG 25 North America AI In Drug Repurposing Market, 2021 - 2032, USD Million
  • FIG 26 North America AI In Drug Repurposing Market share by Component, 2024
  • FIG 27 North America AI In Drug Repurposing Market share by Component, 2032
  • FIG 28 North America AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
  • FIG 29 North America AI In Drug Repurposing Market share by Technology, 2024
  • FIG 30 North America AI In Drug Repurposing Market share by Technology, 2032
  • FIG 31 North America AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
  • FIG 32 North America AI In Drug Repurposing Market share by End Use, 2024
  • FIG 33 North America AI In Drug Repurposing Market share by End Use, 2032
  • FIG 34 North America AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
  • FIG 35 North America AI In Drug Repurposing Market share by Application, 2024
  • FIG 36 North America AI In Drug Repurposing Market share by Application, 2032
  • FIG 37 North America AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
  • FIG 38 North America AI In Drug Repurposing Market share by Country, 2024
  • FIG 39 North America AI In Drug Repurposing Market share by Country, 2032
  • FIG 40 North America AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
  • FIG 41 Key Factors Impacting Europe AI In Drug Repurposing Market
  • FIG 42 Europe AI In Drug Repurposing Market, 2021 - 2032, USD Million
  • FIG 43 Europe AI In Drug Repurposing Market share by Component, 2024
  • FIG 44 Europe AI In Drug Repurposing Market share by Component, 2032
  • FIG 45 Europe AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
  • FIG 46 Europe AI In Drug Repurposing Market share by Technology, 2024
  • FIG 47 Europe AI In Drug Repurposing Market share by Technology, 2032
  • FIG 48 Europe AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
  • FIG 49 Europe AI In Drug Repurposing Market share by End Use, 2024
  • FIG 50 Europe AI In Drug Repurposing Market share by End Use, 2032
  • FIG 51 Europe AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
  • FIG 52 Europe AI In Drug Repurposing Market share by Application, 2024
  • FIG 53 Europe AI In Drug Repurposing Market share by Application, 2032
  • FIG 54 Europe AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
  • FIG 55 Europe AI In Drug Repurposing Market share by Country, 2024
  • FIG 56 Europe AI In Drug Repurposing Market share by Country, 2032
  • FIG 57 Europe AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
  • FIG 58 Key Factors Impacting asia pacific ai in drug repurposing Market
  • FIG 59 Asia Pacific AI In Drug Repurposing Market, 2021 - 2032, USD Million
  • FIG 60 Asia Pacific AI In Drug Repurposing Market share by Component, 2024
  • FIG 61 Asia Pacific AI In Drug Repurposing Market share by Component, 2032
  • FIG 62 Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
  • FIG 63 Asia Pacific AI In Drug Repurposing Market share by Technology, 2024
  • FIG 64 Asia Pacific AI In Drug Repurposing Market share by Technology, 2032
  • FIG 65 Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
  • FIG 66 Asia Pacific AI In Drug Repurposing Market share by End Use, 2024
  • FIG 67 Asia Pacific AI In Drug Repurposing Market share by End Use, 2032
  • FIG 68 Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
  • FIG 69 Asia Pacific AI In Drug Repurposing Market share by Application, 2024
  • FIG 70 Asia Pacific AI In Drug Repurposing Market share by Application, 2032
  • FIG 71 Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
  • FIG 72 Asia Pacific AI In Drug Repurposing Market share by Country, 2024
  • FIG 73 Asia Pacific AI In Drug Repurposing Market share by Country, 2032
  • FIG 74 Asia Pacific AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
  • FIG 75 Key Factors Impacting lamea AI In Drug Repurposing Market
  • FIG 76 LAMEA AI In Drug Repurposing Market, 2021 - 2032, USD Million
  • FIG 77 LAMEA AI In Drug Repurposing Market share by Component, 2024
  • FIG 78 LAMEA AI In Drug Repurposing Market share by Component, 2032
  • FIG 79 LAMEA AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
  • FIG 80 LAMEA AI In Drug Repurposing Market share by Technology, 2024
  • FIG 81 LAMEA AI In Drug Repurposing Market share by Technology, 2032
  • FIG 82 LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
  • FIG 83 LAMEA AI In Drug Repurposing Market share by End Use, 2024
  • FIG 84 LAMEA AI In Drug Repurposing Market share by End Use, 2032
  • FIG 85 LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
  • FIG 86 LAMEA AI In Drug Repurposing Market share by Application, 2024
  • FIG 87 LAMEA AI In Drug Repurposing Market share by Application, 2032
  • FIG 88 LAMEA AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
  • FIG 89 LAMEA AI In Drug Repurposing Market share by Country, 2024
  • FIG 90 LAMEA AI In Drug Repurposing Market share by Country, 2032
  • FIG 91 LAMEA AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
  • FIG 92 Swot Analysis: Ginkgo Bioworks
  • FIG 93 SWOT Analysis: IBM Corporation
  • FIG 94 SWOT Analysis: Novartis AG
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!